| Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? AM Darwesh, W Bassiouni, DK Sosnowski, JM Seubert Pharmacology & therapeutics 219, 107703, 2021 | 73 | 2021 |
| Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system AM Darwesh, DK Sosnowski, TYT Lee, H Keshavarz-Bahaghighat, ... Chemico-biological interactions 308, 20-44, 2019 | 46 | 2019 |
| Sex-and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility A Viveiros, M Gheblawi, PK Aujla, DK Sosnowski, JM Seubert, Z Kassiri, ... Journal of molecular and cellular cardiology 164, 13-16, 2022 | 40 | 2022 |
| Mitochondrial dysfunction and inflammaging in heart failure: novel roles of CYP-derived epoxylipids H Keshavarz-Bahaghighat, AM Darwesh, DK Sosnowski, JM Seubert Cells 9 (7), 1565, 2020 | 36 | 2020 |
| Age and sex differences in hearts of soluble epoxide hydrolase null mice KL Jamieson, H Keshavarz-Bahaghighat, AM Darwesh, DK Sosnowski, ... Frontiers in Physiology 11, 48, 2020 | 22 | 2020 |
| Soluble epoxide hydrolase in aged female mice and human explanted hearts following ischemic injury KL Jamieson, AM Darwesh, DK Sosnowski, H Zhang, S Shah, ... International Journal of Molecular Sciences 22 (4), 1691, 2021 | 15 | 2021 |
| Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function DK Sosnowski, KL Jamieson, A Gruzdev, Y Li, R Valencia, A Yousef, ... American Journal of Physiology-Heart and Circulatory Physiology 323 (4 …, 2022 | 11 | 2022 |
| An inflammation resolution–promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction R Hiram, F Xiong, P Naud, J Xiao, DK Sosnowski, E Le Quilliec, A Saljic, ... Cardiovascular Research 120 (4), 345-359, 2024 | 5 | 2024 |
| Changes in the left ventricular eicosanoid profile in human dilated cardiomyopathy DK Sosnowski, KL Jamieson, AM Darwesh, H Zhang, ... Frontiers in Cardiovascular Medicine 9, 879209, 2022 | 5 | 2022 |
| Cardioprotective response and senescence in aged sEH null female mice exposed to LPS A Yousef, DK Sosnowski, L Fang, RJ Legaspi, J Korodimas, A Lee, ... American Journal of Physiology-Heart and Circulatory Physiology 326 (6 …, 2024 | | 2024 |
| Genetic Atrial Cardiomyopathies: Common Features, Specific Differences, and Broader Relevance to Understanding Atrial Cardiomyopathy E Marcoux, D Sosnowski, S Ninni, M Mackasey, J Cadrin-Tourigny, ... Circulation: Arrhythmia and Electrophysiology 16 (12), 675-698, 2023 | | 2023 |
| Resolving Unchecked Inflammation in Atrial Fibrillation D Sosnowski, R Hiram, XY Qi, K Bourque, P Naud, S Ninni, D Pétrin, ... Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| CYP-Derived metabolites of Omega-3 fatty acids protect your heart A Darwesh, D Sosnowski, R Valencia, A Konkel, J Falck, WH Schunck, ... Journal of Molecular and Cellular Cardiology 173, S13, 2022 | | 2022 |
| Myocardial Ischemia and Inflammation: Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function DK Sosnowski, KL Jamieson, A Gruzdev, Y Li, R Valencia, A Yousef, ... American Journal of Physiology-Heart and Circulatory Physiology 323 (4), H670, 2022 | | 2022 |
| Effects of Genetic Deletion of Soluble Epoxide Hydrolase on Cardiac Function and Inflammation in Acute Lipopolysaccharide Injury D Sosnowski | | 2022 |
| Genetic deletion of soluble epoxide hydrolase preserves cardiac function and limits inflammation in acute lipopolysaccharide injury D Sosnowski, K Jamieson, A Darwesh, A Gruzdev, D Zeldin, J Seubert The FASEB Journal 35, 2021 | | 2021 |
| Pharmacologic Inhibition or Genetic Deletion of Soluble Epoxide Hydrolase Improves Survival Following Myocardial Infarction in Aged Mice L Jamieson, DK Sosnowski, AM Darweshe, W Wang, P Zhabyeyev, ... The FASEB Journal 33 (S1), 817.8-817.8, 2019 | | 2019 |
